Pharmaceutical Emulsions: A Viable Approach for Ocular Drug Delivery.
暂无分享,去创建一个
R. Bhatta | M. Mugale | K. Yadav | Anjali Mishra | Arpon Biswas | Abhijit Deb Choudhury | S. Sanap | A. C. Bisen | Ayush Dubey | Saurabh Srivastava | Neeraj Mohan Gupta
[1] R. Bhatta,et al. Solanum nigrum Toxicity and Its Neuroprotective Effect Against Retinal Ganglion Cell Death Through Modulation of Extracellular Matrix in a Glaucoma Rat Model. , 2024, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[2] R. Bhatta,et al. Ocular bioanalysis of moxifloxacin and ketorolac tromethamine in rabbit lacrimal matrix using liquid chromatography-tandem mass spectrometry. , 2024, Bioanalysis.
[3] Mukesh Kumar,et al. Simultaneous determination of amphotericin B, tobramycin and vancomycin in rabbit ocular biofluids and tissues by LC-MS/MS: An antimicrobial therapy for keratitis and its PK-PD application. , 2023, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[4] Mukesh Kumar,et al. Concurrent determination of anti-microbial and anti-inflammatory drugs in lachrymal fluid and tissue by LC-MS/MS: A potential treatment for microbial keratitis and its PK-PD evaluation. , 2023, Journal of pharmaceutical and biomedical analysis.
[5] R. Bhatta,et al. Trends in Formulation Approaches for Sustained Drug Delivery to the Posterior Segment of the Eye , 2023, AAPS PharmSciTech.
[6] K. Yadav,et al. Microemulsions for Enhancing Drug Delivery of Hydrophilic Drugs: Exploring Various Routes of Administration , 2023, Medicine in Drug Discovery.
[7] Mukesh Kumar,et al. Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management. , 2023, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[8] D. Ghiglioni,et al. Vernal Keratoconjunctivitis: A Systematic Review , 2023, Clinical Reviews in Allergy & Immunology.
[9] Xu Liu,et al. Antioxidant nanoemulsion loaded with latanoprost enables highly effective glaucoma treatment. , 2023, Journal of controlled release : official journal of the Controlled Release Society.
[10] R. Bhatta,et al. Ophthalmic nano-bioconjugates: critical challenges and technological advances. , 2023, Therapeutic delivery.
[11] Yao Fu,et al. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects , 2023, Journal of Nanobiotechnology.
[12] Mukesh Kumar,et al. A QbD-led Simple and Sensitive RP-UHPLC method for Simultaneous Determination of Moxifloxacin, Voriconazole, and Pirfenidone: An Application to Pharmaceutical Analysis. , 2023, Biomedical chromatography : BMC.
[13] R. Bhatta,et al. Simultaneous estimation of voriconazole, moxifloxacin, and pirfenidone in rabbit lacrimal matrix using LC-MS/MS: an application to preclinical ocular pharmacokinetics. , 2023, Analytical methods : advancing methods and applications.
[14] Yanna Zhao,et al. Comparative study of cyclosporine A liposomes and emulsions for ophthalmic drug delivery: Process optimization through response surface methodology (RSM) and biocompatibility evaluation. , 2023, Colloids and surfaces. B, Biointerfaces.
[15] R. K. Ameta,et al. Recent Advances in Improving the Bioavailability of Hydrophobic/Lipophilic Drugs and Their Delivery via Self-Emulsifying Formulations , 2023, Colloids and Interfaces.
[16] M. Amin,et al. Ocular Drug Delivery: a Comprehensive Review , 2023, AAPS PharmSciTech.
[17] S. Safi,et al. Systematic review of clinical practice guidelines for uveitis , 2023, BMJ Open Ophthalmology.
[18] R. Bhatta,et al. Liquid chromatography‐tandem mass spectrometry method for simultaneous assessment of ofloxacin and dexamethasone in ocular biofluids: Application to ocular pharmacokinetic studies , 2022, SEPARATION SCIENCE PLUS.
[19] C. Y. Chee,et al. Review of Functional Aspects of Nanocellulose-Based Pickering Emulsifier for Non-Toxic Application and Its Colloid Stabilization Mechanism , 2022, Molecules.
[20] R. Agrawal,et al. Nonsurgical Management of Severe Viral Keratitis with Hypopyon and Retrocorneal Plaques: A Case Series , 2022, Ophthalmology and Therapy.
[21] Anroop B Nair,et al. Enhanced anti-cataract effect of microemulsion containing Cineraria maritima: Formulation, optimization and in vivo evaluation , 2022, Journal of Drug Delivery Science and Technology.
[22] S. Chopra,et al. Chitosan/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitis. , 2022, International journal of biological macromolecules.
[23] Arash Omidtabrizi,et al. Acute retinal necrosis. Management and visual outcomes: a case series , 2022, International Journal of Retina and Vitreous.
[24] R. Bhatta,et al. A recent update on therapeutic potential of vesicular system against fungal keratitis , 2022, Journal of Drug Delivery Science and Technology.
[25] A. Fea,et al. Glaucoma Treatment and Hydrogel: Current Insights and State of the Art , 2022, Gels.
[26] Shinji Watanabe,et al. Applications of Medium-Chain Triglycerides in Foods , 2022, Frontiers in Nutrition.
[27] S. Chopra,et al. QbD based antifungal drug-loaded ophthalmic liposomal formulation for the management of fungal keratitis: In vitro, ex vivo and in vivo pharmacokinetic studies , 2022, Journal of Drug Delivery Science and Technology.
[28] S. Karthikeyan,et al. Novel angular binary pattern (NABP) and kernel based convolutional neural networks classifier for cataract detection , 2022, Multimedia Tools and Applications.
[29] Prawej Ansari,et al. Diabetic Retinopathy: An Overview on Mechanisms, Pathophysiology and Pharmacotherapy , 2022, Diabetology.
[30] Mohammad Y. Alshahrani,et al. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System , 2022, Gels.
[31] J. Manwar,et al. A CRITICAL REVIEW ON NANOEMULSION: ADVANTAGES, TECHNIQUES AND CHARACTERIZATION , 2022, Journal of Applied Pharmaceutical Sciences and Research.
[32] J. Walsh,et al. Targeting Ocular Drug Delivery: An Examination of Local Anatomy and Current Approaches , 2022, Bioengineering.
[33] K. B. Shah,et al. Cyclosporine release and distribution in ophthalmic emulsions determined by pulsatile microdialysis. , 2022, International journal of pharmaceutics.
[34] Jian-xing Ma,et al. Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization , 2021, Biology.
[35] R. Bhatta,et al. Simultaneous determination of fluconazole and ofloxacin in rabbit tear fluid by LC-MS/MS: Application to ocular pharmacokinetic studies. , 2021, Journal of pharmaceutical and biomedical analysis.
[36] J. Grauslund,et al. Topical treatment of diabetic retinopathy: a systematic review , 2021, Acta ophthalmologica.
[37] Mohammad Mehdi Mahboobian,et al. Acyclovir-Loaded Nanoemulsions: Preparation, Characterization and Irritancy Studies for Ophthalmic Delivery , 2021, Current eye research.
[38] C. Strachan,et al. Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin , 2021, Pharmaceutics.
[39] Mohammad Mehdi Mahboobian,et al. Besifloxacin-loaded ocular nanoemulsions: design, formulation and efficacy evaluation , 2021, Drug Delivery and Translational Research.
[40] J. Hadžiabdić,et al. Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions , 2020, Pharmaceutics.
[41] A. Bernkop‐Schnürch,et al. Strategies to prolong the residence time of drug delivery systems on ocular surface. , 2020, Advances in colloid and interface science.
[42] P. Shukla,et al. Topical corneal targeted sustained release amphotericin B liposomal formulation for the treatment of fungal keratitis and its PK-PD evaluation , 2020 .
[43] J. Jägers,et al. Perfluorocarbon-based oxygen carriers: from physics to physiology , 2020, Pflügers Archiv - European Journal of Physiology.
[44] S. Kang,et al. Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[45] C. Regatieri,et al. Age-related macular degeneration: a review of current therapies and new treatments. , 2020, Arquivos brasileiros de oftalmologia.
[46] A. Al-Nima,et al. Nanoemulsions as Ophthalmic Drug Delivery Systems , 2020, Turkish journal of pharmaceutical sciences.
[47] S. Pflugfelder,et al. Biological functions of tear film. , 2020, Experimental eye research.
[48] Vivek,et al. Role of Micro Emulsion Based In-Situ Gelling System of Fluoroquinolone for Treatment of Posterior Segment Eye Diseases (PSED) , 2020 .
[49] P. Siafaka,et al. Novel Ocular Drug Delivery Systems: An Update on Microemulsions. , 2020, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[50] Minxin Zhang,et al. Cationic Nanoemulsions with Prolonged Retention Time as Promising Carriers for Ophthalmic Delivery of Tacrolimus. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[51] Lucia Pavoni,et al. An Overview of Micro- and Nanoemulsions as Vehicles for Essential Oils: Formulation, Preparation and Stability , 2020, Nanomaterials.
[52] M. Lake,et al. A Supersaturated Oxygen Emulsion for the Topical Treatment of Ocular Trauma. , 2019, Military medicine.
[53] M. Pellegrini,et al. Assessment of Corneal Fluorescein Staining in Different Dry Eye Subtypes Using Digital Image Analysis , 2019, Translational vision science & technology.
[54] E. Sánchez-López,et al. Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents , 2019, Pharmaceutics.
[55] N. Biswas,et al. Comparison of ocular pharmacokinetics of etoposide and its nanoemulsion after subtenon administration in rabbits , 2019, Journal of basic and clinical physiology and pharmacology.
[56] Pierre P. D. Kondiah,et al. Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery , 2019, Polymers.
[57] Hari Prasad Devkota,et al. Medicinal Plants and Natural Products Used in Cataract Management , 2019, Front. Pharmacol..
[58] Md. Akhlaquer Rahman,et al. Nanoemulsion: Promising nanocarrier system for delivery of herbal bioactives , 2019, Journal of Drug Delivery Science and Technology.
[59] J. Németh,et al. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study. , 2019, Ophthalmology.
[60] N. Anton,et al. Double emulsions prepared by two–step emulsification: History, state‐of‐the‐art and perspective , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[61] A. Mitra,et al. Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease , 2019, Pharmaceutical Research.
[62] Sangsub Jung,et al. High-throughput toxicity study of lubricant emulsions and their common ingredients using zebrafish , 2018, PloS one.
[63] O. Martín‐Belloso,et al. Beverage Emulsions: Key Aspects of Their Formulation and Physicochemical Stability , 2018, Beverages.
[64] C. Georgakopoulos,et al. An eye for azithromycin: review of the literature , 2018, Therapeutic advances in ophthalmology.
[65] Arturo Santos,et al. Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery. , 2018, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[66] Rahul Tiwari,et al. Therapeutic challenges in ocular delivery of lipid based emulsion , 2018, Egyptian Journal of Basic and Applied Sciences.
[67] Rinda Devi Bachu,et al. Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases , 2018, Pharmaceutics.
[68] Sheridan M. Hoy. Ciclosporin Ophthalmic Emulsion 0.1%: A Review in Severe Dry Eye Disease , 2017, Drugs.
[69] R. Gurny,et al. Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[70] K. Shah,et al. Emulsion of Chloramphenicol: an Overwhelming Approach for Ocular Delivery , 2017, Folia medica.
[71] Eun Seong Lee,et al. Preparation and characterization of a lutein loading nanoemulsion system for ophthalmic eye drops , 2016 .
[72] S. Deore,et al. Emulsion Micro Emulsion and Nano Emulsion: A Review , 2016 .
[73] Animikh Ray,et al. A comprehensive insight on ocular pharmacokinetics , 2016, Drug Delivery and Translational Research.
[74] H. Takeuchi,et al. Effect of high-pressure homogenization on stability of emulsions containing zein and pectin , 2016, Asian journal of pharmaceutical sciences.
[75] R. Rejdak,et al. Drug bioavailability from topically applied ocular drops. Does drop size matter , 2016 .
[76] A. Mitra,et al. Novel strategies for the treatment of diabetic macular edema , 2016 .
[77] H. Lew,et al. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy , 2016, Korean journal of ophthalmology : KJO.
[78] Sharul Sham Dol,et al. Crude oil emulsion: A review on formation, classification and stability of water-in-oil emulsions , 2015 .
[79] T. Wong,et al. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss , 2015, Eye and Vision.
[80] A. Galor,et al. Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence. , 2015, Clinical investigation.
[81] Dawood Aghadoost. Ocular Trauma: An Overview , 2014, Archives of trauma research.
[82] J. Pluta,et al. Ophthalmic Drug Dosage Forms: Characterisation and Research Methods , 2014, TheScientificWorldJournal.
[83] Amitava Ghosh,et al. Microemulsion: New Insights into the Ocular Drug Delivery , 2013, ISRN pharmaceutics.
[84] A. Mitra,et al. Ocular drug delivery systems: An overview. , 2013, World journal of pharmacology.
[85] A. Mitra,et al. Novel strategies for anterior segment ocular drug delivery. , 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[86] P. Daull,et al. A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[87] F. Lallemand,et al. Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb , 2012, Journal of drug delivery.
[88] C. Foster,et al. Difluprednate for inflammatory eye disorders. , 2011, Drugs of today.
[89] Terry Kim,et al. Anatomy and physiology of the cornea , 2011, Journal of cataract and refractive surgery.
[90] S. Majumdar,et al. Injectable Lipid Emulsions—Advancements, Opportunities and Challenges , 2010, AAPS PharmSciTech.
[91] A. Mitra,et al. Ocular Drug Delivery , 2010, The AAPS Journal.
[92] H. Yamashita,et al. Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[93] Maria Jose Alonso,et al. Chitosan-based nanostructures: a delivery platform for ocular therapeutics. , 2010, Advanced drug delivery reviews.
[94] D. Callanan,et al. The role of difluprednate ophthalmic emulsion in clinical practice , 2009, Clinical ophthalmology.
[95] Xing Tang,et al. Lipid emulsions as a potential delivery system for ocular use of azithromycin , 2009, Drug development and industrial pharmacy.
[96] Y. Chevalier,et al. Topical delivery of lipophilic drugs from o/w Pickering emulsions. , 2009, International journal of pharmaceutics.
[97] Jim Jiao. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. , 2008, Advanced drug delivery reviews.
[98] Sushma Talegaonkar,et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[99] C. Klaver,et al. Age-related macular degeneration , 2006, BMJ : British Medical Journal.
[100] S. Best. Glaucoma Diagnosis and Management , 2006 .
[101] A. Mitra,et al. Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea. , 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[102] T. Rades,et al. W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[103] Makiko Yamamoto,et al. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. , 2005, International journal of pharmaceutics.
[104] Simon Benita,et al. The potential of lipid emulsion for ocular delivery of lipophilic drugs. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[105] H. Shichi. Cataract formation and prevention , 2004, Expert opinion on investigational drugs.
[106] S. Dinslage,et al. A comparative bioavailability study of three conventional eye drops versus a single lyophilisate , 2003, The British journal of ophthalmology.
[107] S. Perfetti,et al. Glaucoma and quality of the life , 1998, Acta ophthalmologica Scandinavica. Supplement.
[108] D. Brossard,et al. Amphotericin B eye drops as a lipidic emulsion , 1996 .
[109] S. Nazir,et al. Chloramphenicol Loaded Microemulsions: Development, Characterization and Stability , 2019, Colloid and Interface Science Communications.
[110] S. Doktorovová,et al. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part I – Barriers and determining factors in ocular delivery , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[111] R. Moots,et al. Behcet's disease , 2017, Clinical medicine.
[112] A. Acheampong,et al. Ocular Pharmacokinetics and Safety of Ciclosporin, a Novel Topical Treatment for Dry Eye , 2005, Clinical pharmacokinetics.
[113] J. W. Shell. Ocular Drug Delivery Systems - A Review , 1982 .